Predictive and prognostic biomarker discovery for brain disorders

Slight modifications to glycoproteins reveal critical insights into disease onset, state, and progression, making them a wellspring for biomarker discovery. 

Glycoproteins play key roles in various biological processes, such as cell signaling, adhesion, and cell-cell communication. Slight changes to the composition of these fundamental proteins often correlate with disease onset and progression, making them valuable indicators of disease state and treatment efficacy. In this webinar, Yehia Mechref will discuss how to leverage proteomics and glycoproteomics tools to identify predictive biomarkers of neurodegenerative diseases and traumatic brain injury. 

Topics to be covered

  • Using glycoproteins as effective predictors of neurodegenerative diseases, including Alzheimer's and Parkinson’s diseases
  • Detecting glycoproteins predictors of traumatic brain injury

Thursday, March 21st, 2024 | 1:00 PM - 2:00 PM Eastern Time
This webinar will be available to view live and on demand.


Yehia Mechref, PhD

Yehia Mechref, PhD

Director, Center for Biotechnology and Genomics 
Texas Tech University

Supported by